| Literature DB >> 22998874 |
Gulayse Ince-Dunn1, Hirotaka J Okano, Kirk B Jensen, Woong-Yang Park, Ru Zhong, Jernej Ule, Aldo Mele, John J Fak, Chingwen Yang, Chaolin Zhang, Jong Yoo, Margaret Herre, Hideyuki Okano, Jeffrey L Noebels, Robert B Darnell.
Abstract
The paraneoplastic neurologic disorders target several families of neuron-specific RNA binding proteins (RNABPs), revealing that there are unique aspects of gene expression regulation in the mammalian brain. Here, we used HITS-CLIP to determine robust binding sites targeted by the neuronal Elav-like (nElavl) RNABPs. Surprisingly, nElav protein binds preferentially to GU-rich sequences in vivo and in vitro, with secondary binding to AU-rich sequences. nElavl null mice were used to validate the consequence of these binding events in the brain, demonstrating that they bind intronic sequences in a position dependent manner to regulate alternative splicing and to 3'UTR sequences to regulate mRNA levels. These controls converge on the glutamate synthesis pathway in neurons; nElavl proteins are required to maintain neurotransmitter glutamate levels, and the lack of nElavl leads to spontaneous epileptic seizure activity. The genome-wide analysis of nElavl targets reveals that one function of neuron-specific RNABPs is to control excitation-inhibition balance in the brain.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22998874 PMCID: PMC3517991 DOI: 10.1016/j.neuron.2012.07.009
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 17.173